Search research articles
Contact Us
Filters
Showing results (231-240 of 260) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.
European Urology Oncology
|
August 6, 2021
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer
Tessel E Galesloot, Anne J Grotenhuis, Dimitar Kolev, et al.
Cancer Genetics
|
June 19, 2026
Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer
Jasper P Hof, Tessel E Galesloot, Katja K H Aben, et al.
Frontiers in Oncology
|
January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
Aaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial
Neil E Fleshner, Rashid K Sayyid, Aaron R Hansen, et al.
Urologic Oncology
|
February 22, 2020
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
Thomas Hermanns, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Endocrine Oncology (Bristol, England)
|
July 3, 2026
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer
Mathew Gorman, Nawaid Usmani, Michael N Pollak, et al.
European Urology
|
March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis
Rachel M Glicksman, Ur Metser, Douglass Vines, et al.
European Urology
|
April 12, 2011
Active surveillance of small renal masses: progression patterns of early stage kidney cancer
Michael A S Jewett, Kamal Mattar, Joan Basiuk, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 260) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2017
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Girish S Kulkarni, Thomas Hermanns, Yanliang Wei, et al.
European Urology Oncology
|
August 6, 2021
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer
Tessel E Galesloot, Anne J Grotenhuis, Dimitar Kolev, et al.
Cancer Genetics
|
June 19, 2026
Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer
Jasper P Hof, Tessel E Galesloot, Katja K H Aben, et al.
Frontiers in Oncology
|
January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
Aaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial
Neil E Fleshner, Rashid K Sayyid, Aaron R Hansen, et al.
Urologic Oncology
|
February 22, 2020
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
Thomas Hermanns, Andrea J Savio, Ekaterina Olkhov-Mitsel, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Endocrine Oncology (Bristol, England)
|
July 3, 2026
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer
Mathew Gorman, Nawaid Usmani, Michael N Pollak, et al.
European Urology
|
March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis
Rachel M Glicksman, Ur Metser, Douglass Vines, et al.
European Urology
|
April 12, 2011
Active surveillance of small renal masses: progression patterns of early stage kidney cancer
Michael A S Jewett, Kamal Mattar, Joan Basiuk, et al.
Page
of 26